No supplier or customer ties in TKNO's filings yet. The map draws only what companies disclose to the SEC; ties named in other companies' filings join as the graph reads them.
Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It serves life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and government research institutions. The company was founded in 1996 and is headquartered in Hollister, California.
Nothing on the wire mentions TKNO yet. Iris sweeps the public feeds every quarter hour; headlines land here the moment a sweep tags them.
How TKNO has moved on past release days vs its typical ±4.1% day, and how often it closed up. Computed from daily closes — not a forecast.